Foundation News

NEW YORK, NY – The Crohn’s & Colitis Foundation announced today that it is presenting its Uniting to Care & Cure Awards to 16 healthcare providers from across the country in recognition of their work to help find cures for inflammatory bowel disease (IBD) and improve the quality of life o

NEW YORK, NY – The Crohn’s & Colitis Foundation (the Foundation) has named Dr. David T.

New York, NY – For Crohn’s disease patients with mild-to-moderate symptoms, a Mediterranean style diet and the Specific Carbohydrate Diet™appear to improve symptoms and quality of life, according to a new study published

Check out our May 2021 Chapter Newsletter

The Crohn’s & Colitis Foundation announced today that it has received a $3.3 million grant from The Leona M. and Harry B. Helmsley Charitable Trust to improve the urgent care management of Crohn’s disease through IBD Qorus®, the Foundation’s flagship quality of care program.

Progenity, Inc., a biotechnology company with an established track record of success developing and commercializing molecular testing products, announced today that it has received funding from the Crohn’s & Colitis Foundation’s IBD Ventures program to further develop Progenity’s first-in-class oral Drug Delivery System (DDS) for delivery of targeted therapeutics for inflammatory bowel disease (IBD).

April is National Minority Health Month (NMHM), a time to raise awareness about health disparities that continue to affect racial and ethnic minority populations and encourage action through health education, early detection, and control of disease complications.

We are excited to announce the2021 Rising Healthcare Leader in IBD- Dr. Sarah Flier!

My son Robert was diagnosed with Crohn’s disease when he was 15. He is now 21 and in remission. I give so much credit to the Crohn’s & Colitis Foundation for all the research and fundraising that they have done over the years...